Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RGNX
RGNX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RGNX News
Notice of REGENXBIO Securities Class Action
6d ago
PRnewswire
Capricor's Former Executive Considered for FDA Biologics Chief
6d ago
stocktwits
Regenxbio Faces Class Action for Securities Fraud
Apr 13 2026
Globenewswire
Regenxbio Faces Class Action Lawsuit Reminder
Apr 13 2026
PRnewswire
REGENXBIO Class Action Lawsuit Notice
Apr 12 2026
Globenewswire
Faruqi & Faruqi Encourages REGENXBIO Investors to Reach Out
Apr 10 2026
PRnewswire
Notice of REGENXBIO Securities Class Action
Apr 09 2026
PRnewswire
Notice of Class Action Lawsuit Against REGENXBIO Securities
Apr 09 2026
Globenewswire
REGENXBIO Faces Class Action Lawsuit Over Securities Violations
Apr 09 2026
Globenewswire
Regenxbio Faces Class Action Lawsuit Reminder
Apr 09 2026
Globenewswire
REGENXBIO Faces Class Action Lawsuit Over Securities Violations
Apr 06 2026
Globenewswire
Regenxbio Faces Class Action Lawsuit Reminder
Apr 06 2026
Globenewswire
Notice of Class Action Lawsuit for REGENXBIO Securities
Apr 06 2026
Globenewswire
Notice of Class Action Lawsuit for REGENXBIO Securities
Apr 05 2026
Globenewswire
Faruqi & Faruqi Investigates Potential Claims Against REGENXBIO
Apr 04 2026
PRnewswire
Notice of Class Action Lawsuit for REGENXBIO Securities
Apr 03 2026
PRnewswire
Show More News
